EGFR and colorectal carcinoma: Recently, EGFR/BRAF‐targeted therapy ± chemotherapy has been explored as the frontline approach for BRAF V600E mutant mCRC in ANCHOR‐CRC (NCT03693170) and the BREAKWATER trial (NCT01640405).25